Zoetis reports Q4 adjusted EPS $1.15, consensus $1.05

Reports Q4 revenue $2.04B, consensus $2.01B. "In 2022, Zoetis delivered another strong year of performance thanks to our diverse portfolio, global scale and talented colleagues," said Kristin Peck, CEO of Zoetis. "We grew revenue 8% operationally, driven by our innovative companion animal franchises across parasiticides, dermatology and pain. We also grew our adjusted net income faster than sales for the year, at 11% operationally, while continuing to support investments in R&D, manufacturing capacity, and sales and marketing efforts that will drive future growth."